Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Oct;66(4):724-9.
doi: 10.1016/j.eururo.2014.06.036. Epub 2014 Jul 9.

Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030

Jodi A Antonelli  1 , Naim M Maalouf  1 , Margaret S Pearle  1 , Yair Lotan  2
Affiliations

Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030

Jodi A Antonelli et al. Eur Urol. 2014 Oct.

Abstract

Background: The prevalence of urolithiasis and its risk factors such as obesity and diabetes have increased over time.

Objective: Determine the future cost and prevalence of kidney stones using current and projected estimates for stones, obesity, diabetes, and population rates.

Design, setting, and participants: The stone prevalence in 2000 was estimated from the National Health and Nutrition Examination Survey (NHANES) 1988-1994 and 2007-2010. The cost per percentage prevalence of stones in 2000, calculated using Urologic Diseases in America Project data, was used to estimate the annual cost of stones in 2030, adjusting for inflation and increases in population, stone prevalence, obesity and diabetes rates.

Outcome measurements and statistical analysis: The primary outcome was prevalence and cost of stones in 2030. The secondary outcomes were the impact of obesity and diabetes on these values, calculated using odds ratios for stones by body mass index and diabetes status.

Results and limitations: The annual cost of stone disease in 2000, adjusted for inflation to 2014 US dollars, was approximately $2.81 billion. After accounting for increases in population and stone prevalence from 2000, the estimated cost of stones in 2007 in 2014 US dollars was $3.79 billion. Future population growth alone would increase the cost of stone disease by $780 million in 2030. Based on projected estimates for 2030, obesity will independently increase stone prevalence by 0.36%, with an annual cost increase of $157 million. Diabetes will independently increase stone prevalence by 0.72%, associated with a cost increase of $308 million annually by 2030. NHANES data, however, capture patient self-assessment rather than medical diagnosis, which is a potential bias.

Conclusions: The rising prevalence of obesity and diabetes, together with population growth, is projected to contribute to dramatic increases in the cost of urolithiasis, with an additional $1.24 billion/yr estimated by 2030.

Patient summary: Obesity, diabetes, and population rates will contribute to an estimated $1.24 billion/yr increase in the cost of kidney stones by 2030.

Keywords: Cost; Diabetes; Obesity; Urolithiasis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cost of stone disease in 2007 and the future based on obesity, diabetes, and population growth
See this image and copyright information in PMC

Comment in

References

    1. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney international. 2003 May;63(5):1817–1823. - PubMed
    1. Scales CD, Jr, Smith AC, Hanley JM, Saigal CS Urologic Diseases in America P. Prevalence of kidney stones in the United States. European urology. 2012 Jul;62(1):160–165. - PMC - PubMed
    1. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009–2010. NCHS data brief. 2012 Jan;(82):1–8. - PubMed
    1. Centers for Disease Control and Prevention. Increasing prevalence of diagnosed diabetes--United States and Puerto Rico, 1995–2010. MMWR. Morbidity and mortality weekly report. 2012 Nov 16;61(45):918–921. - PubMed
    1. Abate N, Chandalia M, Cabo-Chan AV, Jr, Moe OW, Sakhaee K. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney international. 2004 Feb;65(2):386–392. - PubMed

Publication types

MeSH terms